Epilepsy & Behavior

Papers
(The H4-Index of Epilepsy & Behavior is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Meta-analysis of EEG findings in patients with COVID-1975
Seizure as the presenting symptom of COVID-19: A retrospective case series61
The effect of COVID-19 pandemic on seizure control and self-reported stress on patient with epilepsy58
Underutilization of epilepsy surgery: Part I: A scoping review of barriers55
Access to healthcare and prevalence of anxiety and depression in persons with epilepsy during the COVID-19 pandemic: A multicountry online survey54
Epilepsy and COVID-19: Updated evidence and narrative review52
Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: A systematic review52
Ketogenic diet for infants with epilepsy: A literature review51
Status epilepticus and COVID-19: A systematic review49
Counseling of people with epilepsy via telemedicine: Experiences at a German tertiary epilepsy center during the COVID-19 pandemic49
The cerebellum and epilepsy48
Mechanisms of cognitive impairment in temporal lobe epilepsy: A systematic review of resting-state functional connectivity studies45
GABAergic interneurons in epilepsy: More than a simple change in inhibition44
Brain-responsive corticothalamic stimulation in the centromedian nucleus for the treatment of regional neocortical epilepsy44
Evaluating risk to people with epilepsy during the COVID-19 pandemic: Preliminary findings from the COV-E study42
COVID-19 vaccination in patients with epilepsy: First experiences in a German tertiary epilepsy center41
Climate change and epilepsy: Insights from clinical and basic science studies40
Influence of the COVID-19 outbreak in people with epilepsy: Analysis of a Spanish population (EPICOVID registry)39
Epilepsy and the risk of severe coronavirus disease 2019 outcomes: A systematic review, meta-analysis, and meta-regression36
Improved everyday executive functioning following profound reduction in seizure frequency with fenfluramine: Analysis from a phase 3 long-term extension study in children/young adults with Dravet synd35
Analysis of cannabidiol (CBD) and THC in nonprescription consumer products: Implications for patients and practitioners34
Bidirectional relationships of sleep and epilepsy in adults with epilepsy34
Behavioral comorbidities of epilepsy and neuroinflammation: Evidence from experimental and clinical studies34
Seizure clusters, rescue treatments, seizure action plans: Unmet needs and emerging formulations34
Promise of extracellular vesicles for diagnosis and treatment of epilepsy33
Enlightening the neuroprotective effect of quercetin in epilepsy: From mechanism to therapeutic opportunities33
Impact of developmental and epileptic encephalopathies on caregivers: A literature review33
SARS-CoV-2-related rapid reorganization of an epilepsy outpatient clinic from personal appointments to telemedicine services: A German single-center experience32
Examining the patient and caregiver experience with diazepam nasal spray for seizure clusters: Results from an exit survey of a phase 3, open-label, repeat-dose safety study31
Expert Opinion: Managing sleep disturbances in people with epilepsy31
Testing an app-based intervention to improve insomnia in patients with epilepsy: A randomized controlled trial31
0.076714992523193